Table 1.
Patient clinical characteristics.
| DRS group n = 20 |
Control group n = 24 |
||
|---|---|---|---|
| Gender (M : F) | 2 : 18 | P> 0,05 | 6 : 18 |
| Age [mean (SD)] | 63,9 (6,6) | P> 0,05 | 65,9 (10,3) |
| BMI [median (Q1; Q2)] | 28,5 (24,9; 33,6) | P> 0,05 | 27,8 (24,3; 29,3) |
| Smoking (%) | 6 (30%) | P> 0,05 | 3 (12,5%) |
| Diabetes mellitus (%) | 6 (30%) | P> 0,05 | 2 (8,3%) |
| Hypertension (%) | 17 (85%) | P> 0,05 | 19 (79,2%) |
| Hyperlipidemia (%) | 13 (65%) | P> 0,05 | 12 (50%) |
| Medications (%) | |||
| ACE inhibitor | 7 (35%) | P> 0,05 | 12 (50%) |
| Acetylsalicylic acid | 3 (15%) | P> 0,05 | 4 (17%) |
| β-blocker | 7 (35%) | P> 0,05 | 10 (42%) |
| Ca antagonist | 3 (15%) | P> 0,05 | 8 (34%) |
| Diuretic | 7 (35%) | P> 0,05 | 6 (25%) |
| Statin | 6 (30%) | P> 0,05 | 5 (21%) |
| Insulin | 2 (10%) | P> 0,05 | 2 (8,3%) |
| Oral antidiabetic agents | 2 (10%) | P> 0,05 | 2 (8,3%) |
ACE: angiotensin converting enzyme, BMI: body mass index, DM: diabetes mellitus, SD: standard deviation.